Shervani Industrial Syndicate Buyback 2024 vs Zydus Lifesciences Buyback 2024

Comparison between Shervani Industrial Syndicate Buyback 2024 and Zydus Lifesciences Buyback 2024.

Buyback Details

Shervani Industrial Syndicate Buyback 2024 is a Tender Offer buyback proposed to list at BSE while Zydus Lifesciences Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.

 Shervani Industrial Syndicate Ltd.Zydus Lifesciences Ltd.
LogoShervani Industrial Syndicate Buyback 2024 LogoZydus Lifesciences Buyback 2024 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSEBSE, NSE
Face Value₹10 per share₹1 per share
Buyback Price₹510 per share₹1005 per share
Issue Size1,34,000 shares59,70,149 shares
Issue Size (Amount)₹6.83 Crores₹600.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders108 Equity Shares out of every 739 Fully paid-up Equity Shares held on the Record Date.20,100.00
General Category for all other Eligible Shareholders2 Equity Shares out of every 45 Fully paid-up Equity Shares held on the Record Date.113,900.00
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders6 Equity Shares out of every 67 Fully paid-up Equity Shares held on the Record Date.895,523.00
General Category for all other Eligible Shareholders2 Equity Shares out of every 395 Fully paid-up Equity Shares held on the Record Date.5,074,626.00
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead ManagersSumedha Fiscal Services Ltd.ICICI Securities Ltd.
Necessity of the buyback

Buyback is being undertaken, inter-alia, for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding equity shares broadly in proportion to their shareholding, thereby, enhancing the overall return to Shareholders.
  2. The Buyback would help in improving return on equity by reduction in the share capital base and increasing shareholder value in the longer term.
  3. The Buyback gives an option to the shareholders holding equity shares of the Company, who can choose to participate and get cash in lieu of equity shares to be accepted under the Buyback offer or they may choose not to participate and be benefitted of a resultant increase in their percentage shareholding, post the Buyback offer, without additional Investment.

The Buyback will help the company to distribute a part of the surplus cash to its shareholders holding equity shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in the longer term, and improving the return on equity.

Buyback Timetable

Shervani Industrial Syndicate Buyback 2024 and Zydus Lifesciences Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Shervani Industrial Syndicate Buyback 2024 Buyback record date is Mar 07, 2024. Zydus Lifesciences Buyback 2024 Buyback record date is Feb 23, 2024.

 Shervani Industrial Syndicate Ltd.Zydus Lifesciences Ltd.
Record DateMar 07, 2024Feb 23, 2024
Offer Open DateMar 14, 2024Feb 29, 2024
Offer Closure DateMar 20, 2024Mar 06, 2024
Last date for receipt of tender formsMar 20, 2024Mar 06, 2024
Finalisation of buybackMar 26, 2024Mar 13, 2024
Last Date for settlment of bidsMar 27, 2024Mar 14, 2024
Last Date for extinguishment of sharesApr 08, 2024Mar 26, 2024

Financial Details and Other Relevent Information

Comparison of Shervani Industrial Syndicate Buyback 2024 and Zydus Lifesciences Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Shervani Industrial Syndicate Ltd.Zydus Lifesciences Ltd.
Financial

Shervani Industrial Syndicate Limited Financial Information (Restated Consolidated)

Shervani Industrial Syndicate Limited's revenue increased by 183.11% and profit after tax (PAT) rose by 952.26% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets185.39219.60264.04
Revenue28.119.9333.76
Profit After Tax23.63-2.776.66
Net Worth88.7065.6169.06
Reserves and Surplus85.9762.8966.34
Amount in ₹ Crore

Zydus Lifesciences Limited Financial Information (Restated Consolidated)

Zydus Lifesciences Limited's revenue increased by 17.07% and profit after tax (PAT) rose by 78.25% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Revenue9,553.508,160.607,869.30
Profit After Tax1,529.20857.901,476.20
Net Worth17,515.8016,999.6012,992.30
Reserves and Surplus1,801.75
Total Borrowing1,163.204,196.004,583.50
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 525.00 469.30 505.63
Dec-2023 528.70 476.60 503.43
Nov-2023 585.00 440.90 506.79

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 765.50 684.75 719.52
Dec-2023 696.65 630.15 657.86
Nov-2023 649.00 570.35 619.04
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 766.00 685.00 719.72
Dec-2023 696.50 630.00 658.11
Nov-2023 649.05 630.00 619.14

Compare with others

Compare: